225 related articles for article (PubMed ID: 25511749)
1. Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.
Li F; Wei J; Valenzuela NM; Lai C; Zhang Q; Gjertson D; Fishbein MC; Kobashigawa JA; Deng M; Reed EF
J Heart Lung Transplant; 2015 Apr; 34(4):580-587. PubMed ID: 25511749
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts.
Lepin EJ; Zhang Q; Zhang X; Jindra PT; Hong LS; Ayele P; Peralta MV; Gjertson DW; Kobashigawa JA; Wallace WD; Fishbein MC; Reed EF
Am J Transplant; 2006 Jul; 6(7):1560-71. PubMed ID: 16827856
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Endothelial HLA Class II is a Marker of Antibody-Mediated Rejection in Heart Allograft Biopsies.
Cai Q; Moore SA; Hendricks AR; Torrealba JR
Transplant Proc; 2020 May; 52(4):1192-1197. PubMed ID: 32197864
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated S6 ribosomal protein expression by immunohistochemistry correlates with de novo donor-specific HLA antibodies in lung allograft recipients.
Cone BD; Zhang JQ; Sosa RA; Calabrese F; Reed EF; Fishbein GA
J Heart Lung Transplant; 2021 Oct; 40(10):1164-1171. PubMed ID: 34330604
[TBL] [Abstract][Full Text] [Related]
5. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation.
Tible M; Loupy A; Vernerey D; Suberbielle C; Beuscart T; Cazes A; Guillemain R; Amrein C; Pezzella V; Fabiani JN; Nochy D; Hill G; Empana JP; Jouven X; Charron D; Bruneval P; Duong Van Huyen JP
J Heart Lung Transplant; 2013 Aug; 32(8):769-76. PubMed ID: 23856214
[TBL] [Abstract][Full Text] [Related]
6. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.
Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M
Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425
[TBL] [Abstract][Full Text] [Related]
7. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
8. Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.
Loupy A; Duong Van Huyen JP; Hidalgo L; Reeve J; Racapé M; Aubert O; Venner JM; Falmuski K; Bories MC; Beuscart T; Guillemain R; François A; Pattier S; Toquet C; Gay A; Rouvier P; Varnous S; Leprince P; Empana JP; Lefaucheur C; Bruneval P; Jouven X; Halloran PF
Circulation; 2017 Mar; 135(10):917-935. PubMed ID: 28148598
[TBL] [Abstract][Full Text] [Related]
9. Assessing the role of phosphorylated S6 ribosomal protein in the pathological diagnosis of pulmonary antibody-mediated rejection.
Lunardi F; Vedovelli L; Pezzuto F; Le Pavec J; Dorfmuller P; Ivanovic M; Pena T; Wassilew K; Perch M; Hirschi S; Chenard MP; Sosa RA; Goddard M; Neil D; Montero-Fernandez A; Rice A; Cozzi E; Rea F; Levine DJ; Roux A; Fishbein GA; Calabrese F
J Heart Lung Transplant; 2024 Mar; 43(3):403-413. PubMed ID: 37806601
[TBL] [Abstract][Full Text] [Related]
10. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.
Everitt MD; Hammond ME; Snow GL; Stehlik J; Revelo MP; Miller DV; Kaza AK; Budge D; Alharethi R; Molina KM; Kfoury AG
J Heart Lung Transplant; 2012 Jul; 31(7):686-93. PubMed ID: 22551931
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP.
Fedrigo M; Leone O; Burke MM; Rice A; Toquet C; Vernerey D; Frigo AC; Guillemain R; Pattier S; Smith J; Lota A; Potena L; Bontadini A; Ceccarelli C; Poli F; Feltrin G; Gerosa G; Manzan E; Thiene G; Bruneval P; Angelini A; Duong Van Huyen JP
Am J Transplant; 2015 Feb; 15(2):526-34. PubMed ID: 25612500
[TBL] [Abstract][Full Text] [Related]
12. HLA Class II-Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection.
Jin YP; Valenzuela NM; Zhang X; Rozengurt E; Reed EF
J Immunol; 2018 Apr; 200(7):2372-2390. PubMed ID: 29475988
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent specificity of immunopathologic (C4d-CD68) and histologic criteria of antibody-mediated rejection for donor-specific antibodies and allograft dysfunction in heart transplantation.
Yerly P; Rotman S; Nobile A; Aubert V; Tozzi P; Yarol N; Vogt P; Hullin R; Pascual M
Transplantation; 2015 Mar; 99(3):586-93. PubMed ID: 24983305
[TBL] [Abstract][Full Text] [Related]
14. ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.
Hammond MEH; Revelo MP; Miller DV; Snow GL; Budge D; Stehlik J; Molina KM; Selzman CH; Drakos SG; Rami A A; Nativi-Nicolau JN; Reid BB; Kfoury AG
J Heart Lung Transplant; 2016 Mar; 35(3):320-325. PubMed ID: 26970471
[TBL] [Abstract][Full Text] [Related]
15. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts.
Jindra PT; Hsueh A; Hong L; Gjertson D; Shen XD; Gao F; Dang J; Mischel PS; Baldwin WM; Fishbein MC; Kupiec-Weglinski JW; Reed EF
J Immunol; 2008 Feb; 180(4):2214-24. PubMed ID: 18250428
[TBL] [Abstract][Full Text] [Related]
16. Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation.
Fedrigo M; Gambino A; Benazzi E; Poli F; Frigo AC; Tona F; Caforio AL; Castellani C; Toscano G; Feltrin G; Gerosa G; Thiene G; Angelini A
J Heart Lung Transplant; 2011 Dec; 30(12):1381-8. PubMed ID: 21930398
[TBL] [Abstract][Full Text] [Related]
17. Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?
Mohamedali B; Pyle J; Bhat G
Am J Clin Pathol; 2016 Feb; 145(2):238-43. PubMed ID: 26767383
[TBL] [Abstract][Full Text] [Related]
18. Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection.
Afzali B; Chapman E; Racapé M; Adam B; Bruneval P; Gil F; Kim D; Hidalgo L; Campbell P; Sis B; Duong Van Huyen JP; Mengel M
Am J Transplant; 2017 Feb; 17(2):496-505. PubMed ID: 27401781
[TBL] [Abstract][Full Text] [Related]
19. Characterization of c4d immunostaining utilizing paraffin-embedded tissue of nonpresensitized pediatric heart transplant patients.
Galambos C; Feingold B; Webber SA
Pediatr Dev Pathol; 2008; 11(3):181-4. PubMed ID: 17990923
[TBL] [Abstract][Full Text] [Related]
20. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
